BCAM
PFE icon

Boston Common Asset Management’s Pfizer PFE Stock Holding History

Boston Common Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-20,951
Closed -$1.07M – 344
2022
Q4 		$1.07M Buy
20,951
+482
+2% +$23.1K 0.05% 160
2022
Q3 		$896K Buy
20,469
+314
+2% +$15.3K 0.05% 166
2022
Q2 		$1.06M Buy
20,155
+1,699
+9% +$86.6K 0.05% 170
2022
Q1 		$955K Sell
18,456
-2,105
-10% -$109K 0.04% 172
2021
Q4 		$1.21M Buy
20,561
+1,079
+6% +$53.5K 0.05% 165
2021
Q3 		$838K Buy
19,482
+143
+0.7% +$6.33K 0.04% 176
2021
Q2 		$757K Buy
19,339
+1,330
+7% +$51.7K 0.03% 189
2021
Q1 		$652K Buy
18,009
+210
+1% +$7.46K 0.04% 192
2020
Q4 		$655K Buy
+17,799
New +$653K 0.05% 183
2019
Q1 		– Sell
-7,220
Closed -$299K – 189
2018
Q4 		$299K Hold
7,220
– – 0.04% 172
2018
Q3 		$302K Hold
7,220
– – 0.04% 180
2018
Q2 		$249K Hold
7,220
– – 0.03% 186
2018
Q1 		$243K Sell
7,220
-1,742
-19% -$59.9K 0.03% 192
2017
Q4 		$308K Buy
8,962
+1,042
+13% +$35.5K 0.04% 162
2017
Q3 		$268K Buy
+7,920
New +$255K 0.03% 179
2014
Q3 		– Sell
-567
Closed -$16K – 301
2014
Q2 		$16K Hold
567
– – ﹤0.01% 319
2014
Q1 		$17K Buy
+567
New +$16.9K ﹤0.01% 353
2013
Q4 		– Sell
-567
Closed -$15K – 336
2013
Q3 		$15K Hold
567
– – ﹤0.01% 365
2013
Q2 		$15K Buy
+567
New +$15.7K ﹤0.01% 347

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Common Asset Management's PFE Position: Q1 2023 in Review

Boston Common Asset Management sold out of Pfizer (PFE) in Q1 2023, closing a stake of 20,951 shares — an estimated $1.07M sold.

Boston Common Asset Management first reported a position in PFE in Q2 2013 and held it in 19 quarters. The position peaked at $1.21M in Q4 2021. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Boston Common Asset Management reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • Boston Common Asset Management sold 20,951 Pfizer shares in Q1 2023, an estimated $1.07M.
  • Boston Common Asset Management first reported a position in Pfizer in Q2 2013 and held it in 19 quarters.
  • Boston Common Asset Management's Pfizer position peaked at $1.21M in Q4 2021.
  • 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Boston Common Asset Management's 13F filing for Q1 2023, filed 17 May 2023.